Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-25-038563
Filing Date
2025-12-22
Accepted
2025-12-22 17:16:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 nrxp20251219_424b3.htm 424B3 322563
2 nrx.jpg GRAPHIC 12427
  Complete submission text file 0001437749-25-038563.txt   340928
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

EIN.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-288205 | Film No.: 251593450
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)